175 related articles for article (PubMed ID: 10686273)
1. Performance of the enhanced Abbott AxSYM cardiac troponin I reagent in patients with heterophilic antibodies.
Yeo KT; Storm CA; Li Y; Jayne JE; Brough T; Quinn-Hall KS; Fitzmaurice TF
Clin Chim Acta; 2000 Feb; 292(1-2):13-23. PubMed ID: 10686273
[TBL] [Abstract][Full Text] [Related]
2. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies.
Kim WJ; Laterza OF; Hock KG; Pierson-Perry JF; Kaminski DM; Mesguich M; Braconnier F; Zimmermann R; Zaninotto M; Plebani M; Hanna A; Cembrowski GS; Scott MG
Clin Chem; 2002 Jul; 48(7):1028-34. PubMed ID: 12089171
[TBL] [Abstract][Full Text] [Related]
3. Analytic and clinical evaluation of the Abbott AxSYM cardiac troponin I assay.
ver Elst KM; Chapelle JP; Boland P; Demolder JS; Gorus FK
Am J Clin Pathol; 1999 Dec; 112(6):745-52. PubMed ID: 10587695
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care testing: false elevation of cardiac troponin I assayed in the emergency department.
Pernet P; Bénéteau-Burnat B; Hermand C; Vaubourdolle M
Am J Emerg Med; 2008 Oct; 26(8):969.e1-2. PubMed ID: 18926374
[TBL] [Abstract][Full Text] [Related]
5. [Two cases of false troponin I increase in patients with heterophile antibodies].
Cassin M; Cappelletti P; Rubin D; Zaninotto M; Macor F; Nicolosi GL
Ital Heart J Suppl; 2002 Feb; 3(2):235-8. PubMed ID: 11926033
[TBL] [Abstract][Full Text] [Related]
6. False-positive troponin I measured with the Abbott AxSYM attributed to fibrin interference.
Kazmierczak SC; Sekhon H; Richards C
Int J Cardiol; 2005 May; 101(1):27-31. PubMed ID: 15860379
[TBL] [Abstract][Full Text] [Related]
7. False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors.
Dasgupta A; Banerjee SK; Datta P
Am J Clin Pathol; 1999 Dec; 112(6):753-6. PubMed ID: 10587696
[TBL] [Abstract][Full Text] [Related]
8. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system.
Storti S; Prontera C; Parri MS; Iervasi A; Vittorini S; Emdin M; Zucchelli GC; Longombardo G; Migliorini P; Clerico A
Clin Chem Lab Med; 2006; 44(8):1022-9. PubMed ID: 16879072
[TBL] [Abstract][Full Text] [Related]
10. Heterophile antibodies produce spuriously elevated concentrations of cardiac Troponin I in patients with Legionella pneumophila.
García-Mancebo ML; Agulló-Ortuño MT; Gimeno JR; Navarro-Martínez MD; Ruíz-Gómez J; Noguera-Velasco JA
Clin Biochem; 2005 Jun; 38(6):584-7. PubMed ID: 15885241
[TBL] [Abstract][Full Text] [Related]
11. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays.
Dasgupta A; Chow L; Wells A; Datta P
J Clin Lab Anal; 2001; 15(4):175-7. PubMed ID: 11436198
[TBL] [Abstract][Full Text] [Related]
12. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component.
Eriksson S; Junikka M; Laitinen P; Majamaa-Voltti K; Alfthan H; Pettersson K
Clin Chem; 2003 Jul; 49(7):1095-104. PubMed ID: 12816906
[TBL] [Abstract][Full Text] [Related]
13. False-positive AxSYM cardiac troponin I results in a 53-year-old woman.
Knoblock RJ; Lehman CM; Smith RA; Apple FS; Roberts WL
Arch Pathol Lab Med; 2002 May; 126(5):606-9. PubMed ID: 11958670
[TBL] [Abstract][Full Text] [Related]
14. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay.
Reinsberg J
Clin Biochem; 1996 Apr; 29(2):145-8. PubMed ID: 8601323
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of low-positive troponin I by AxSYM and ACS:180.
Lewis JS; Taylor JF; Miklos AZ; Virgo KS; Creer MH; Ritter DG
Am J Clin Pathol; 2001 Sep; 116(3):396-402. PubMed ID: 11554168
[TBL] [Abstract][Full Text] [Related]
16. Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis.
Kenny PR; Finger DR
J Rheumatol; 2005 Jul; 32(7):1258-61. PubMed ID: 15996061
[TBL] [Abstract][Full Text] [Related]
17. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer.
Kuroki M; Matsumoto Y; Arakawa F; Haruno M; Murakami M; Kuwahara M; Ozaki H; Senba T; Matsuoka Y
J Immunol Methods; 1995 Mar; 180(1):81-91. PubMed ID: 7897248
[TBL] [Abstract][Full Text] [Related]
18. Positive interference from contrast media in cardiac troponin I immunoassays.
Lin CT; Lee HC; Voon WC; Yen HW; Tang MH; Chin TT; Chen WR; Chien WT; Lai WT; Sheu SH
Kaohsiung J Med Sci; 2006 Mar; 22(3):107-13. PubMed ID: 16602274
[TBL] [Abstract][Full Text] [Related]
19. Heterophilic antibody interference in an ultra-sensitive 3-site sandwich troponin I immunoassay.
Zhu Y; Jenkins MM; Brass DA; Ravago PG; Horne BD; Dean SB; Drayton N
Clin Chim Acta; 2008 Sep; 395(1-2):181-2. PubMed ID: 18503763
[No Abstract] [Full Text] [Related]
20. Evaluation of analytical performance of the Pathfast cardiac troponin I.
Di Serio F; Caputo M; Zaninotto M; Ottomano C; Plebani M
Clin Chem Lab Med; 2009; 47(7):829-33. PubMed ID: 19453290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
